Key segment results included Software revenue up 9%, Automation up 22%, Red Hat bookings growth at about 20% and revenue up 12%, Data up 7%, Transaction Processing down 3%, and Infrastructure up 15%.

If you have Genmab in your portfolio or you are eyeing the stock for your next move, now is the perfect time to take a closer look. The biotech sector is often a rollercoaster, and Genmab has not been ...

Lennar Corporation is rated Hold; the share price has reached fair value, with limited upside after strong returns. Learn ...

German software maker SAP on Wednesday reported third-quarter revenue below analysts' estimates and forecast full-year cloud ...

If you’re weighing your next move with Honeywell International, there is a lot to unpack. After all, it’s not every day that ...

In a comprehensive analysis of the UK market, Barclays has identified five standout stocks across various sectors, with IWG ...

If you have BAE Systems on your radar, you are definitely not alone. With a five-year return of 424.1% and an eye-catching year-to-date gain of 62.2%, the stock has grabbed attention well beyond its ...

Meta Platforms has gained over 1,200% since 2012. The company is now investing heavily in artificial intelligence, bolstering ...

GERMAN software maker SAP on Wednesday reported third-quarter revenue below analysts' estimates and forecast full-year cloud revenue at the lower end of its outlook range, sending its US-listed shares ...

ClearPath CFO Advisory has announced the regional expansion of its Fractional CFO Services, making strategic financial ...

Another ASX 200 share that has been upgraded by Morgans is health imaging technology company Pro Medicus. While its analysts ...